Source - LSE Regulatory
RNS Number : 9328H
Deltex Medical Group PLC
13 June 2017
 

13 June 2017

Deltex Medical Group plc

 

Director/PDMR Shareholding

 

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), announces that it has received notification that on 12 June 2017 its Chairman, Nigel Keen, transferred 1,996,186 Ordinary Shares into The Imperialise Limited Pension Fund at a price of 4.0p per Ordinary Share. Nigel Keen is the principal beneficiary of this fund and following this transaction his beneficial interest remains 26,193,780 Ordinary Shares in the Company representing 8.82% of the total issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

The following notifications are made in accordance with Article 19 of the EU Market Abuse Regulation

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Keen

2

Reason for the notification

a)

Position/status

Chairman

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Deltex Medical Group plc

b)

LEI

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p each in Deltex Medical Group plc

 

Identification code (ISIN) for Deltex Medical Group plc ordinary shares: GB0059337583

b)

Nature of the transaction

 Transfer of shares into The Imperialise Limited Pension Fund.

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

4.0p

1,996,186

d)

Aggregated information

- Aggregated volume

- Price

 

1,996,186

4.0p

e)

Date of the transaction

12 June 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

For further information, please contact:-

Deltex Medical Group plc                               

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman                


Ewan Phillips, Chief Executive

Jonathan D Shaw, Finance Director        




Nominated Adviser & Broker


Arden Partners plc

020 7614 5900

Chris Hardie

Ciaran Walsh


 

Financial Public Relations


IFC Advisory

0203 053 8671

Tim Metcalfe

Graham Herring

Heather Armstrong


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLIFFTRVIVLID
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.